作者推断,对饮食有过度运动反应症状的肠功能紊乱患者,通过减轻餐后小肠运动活动可望得以缓解。Zamifenacin(Z)是种新的肠选择性M_3毒蕈碱受体抑制剂,效力与阿托品相当,但副作用要少得多。作者对16例健康男性作前膽性随机安慰剂对照研 The authors conclude that patients with bowel dysfunction who have symptoms of excessive exercise response to diet may be relieved by reducing postprandial intestinal motility. Zamifenacin (Z) is a new gut-selective M_3 muscarinic receptor inhibitor with potency equivalent to atropine but with much less side effects. The author of 16 healthy men as a pre-biliary randomized placebo control study